“Aspen Capital has been a true partner for us. They came with a strong understanding of our business as well as the insurance landscape and added value even before their investment closed. They introduced new sales channels, worked hand-in-hand helping refine our GTM approach and have been thought partners every step of the way. Aspen even introduced us to marquee channel partners that significantly advanced our business development function which is now responsible for our largest and most impactful revenue opportunities. The Aspen team has a great balance of operational and investing experience and we are thrilled to have them as partners.”

Acquired by SailPoint (NYSE: SAIL)

“Since making their first investment, Aspen has provided immeasurable support to ERP Maestro. Aspen was engaged in assessing nearly every aspect of the business. They quickly recognized where we needed support and without being overbearing they provided helpful assistance to the Company. They helped us put the scaffolding in place to scale and professionalize the organization and continued to push our thinking to help us get clarity around key strategic decisions. When working with a strategic partner, integrity is very important to us and they did everything they said they would do, and we are thrilled with our partnership. They played a key role in in creating value alongside management which lead to our ultimate sale to SailPoint.”

“Steve Jones of Aspen Capital was instrumental in the growth and development of NeoGenomics. Aspen closed its first investment in 2003 and continued to invest for years as the Company required growth capital. In addition, Steve was deeply involved in helping NeoGenomics refine its business model and strategy, and execute many strategic initiatives. Today, NeoGenomics is a recognized leader in Oncology Diagnostics with a market capitalization over $5 billion and Steve remains a trusted member of our Board.”